• Теги
    • избранные теги
    • Компании987
      • Показать ещё
      Разное233
      • Показать ещё
      Страны / Регионы191
      • Показать ещё
      Международные организации19
      • Показать ещё
      Формат11
      Показатели7
      Издания6
      Люди6
      Сферы1
19 апреля, 23:17

Is J&J's Pharma Sales Slowdown a Warning for Other Players?

Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.

19 апреля, 14:05

Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?

Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

17 апреля, 16:20

5 Drug Stocks That Could Be Big Winners this Earnings Season

Here is a look at five companies including Pfizer (PFE) that sport a favorable Zacks Rank and have a positive earnings ESP.

31 января, 17:29

Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft

Pfizer, Inc. (PFE) missed earnings estimates in the fourth quarter.

31 января, 16:16

Pfizer (PFE) Misses on Q4 Earnings; Tops Sales Estimate

PFE missed fourth quarter earnings which came in at 47 cents while our consensus called for EPS of 50 cents.

25 января, 18:17

What Lies in Store for Pfizer (PFE) this Earnings Season?

Pfizer Inc. (PFE) will be reporting fourth-quarter and full-year 2016 earnings results on Jan 31, before market open.

09 января, 14:09

Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised)

Pfizer, Inc. (PFE) announced positive top-line results from the comparative REFLECTIONS B538-02 study on its investigational compound, PF-06410293, a potential biosimilar to AbbVie Inc.'s (ABBV) Humira.

06 января, 16:21

Pfizer's Humira Biosimilar Meets Primary Endpoint in Study

Pfizer, Inc. (PFE) announced positive top-line results from the comparative REFLECTIONS B538-02 study on its investigational compound, PF-06410293, a potential biosimilar of Humira approved for the treatment of patients with rheumatoid arthritis.

04 января, 14:25

4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017

Pfizer's shares surpassed that of large-cap pharma industry in 2016. The stock rose 0.6% in 2016.

30 декабря 2016, 17:52

Cempra (CEMP) Gets CRL from FDA for Pneumonia Candidate

Cempra (CEMP) announced that it received a CRL from the FDA relating to its new drug applications for oral and intravenous formulation of candidate solithromycin.

01 декабря 2016, 17:08

Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study

Pfizer, Inc. (PFE) recently announced that its experimental biosimilar of Roche Holding AG's (RHHBY) breast cancer drug - Herceptin - has reached the primary endpoint in a pivotal study.

01 ноября 2016, 16:04

Pfizer (PFE) Q3 Earnings Lag; Cuts View, Sheds Bococizumab

Pfizer Inc.'s (PFE) third-quarter adjusted earnings per share came in at 61 cents, a penny below the Zacks Consensus Estimate of 62 cents.

Выбор редакции
01 ноября 2016, 15:35

Pfizer (PFE) Misses on Q3 Earnings and Sales; Lowers View

PFE missed third quarter earnings which came in at 61 cents while our consensus called for EPS of 62 cents

27 октября 2016, 18:37

Pfizer (PFE) to Post Q3 Earnings: How Will the Stock React?

Pfizer Inc. (PFE) will be reporting third-quarter 2016 earnings on Nov 1, before market open.

26 октября 2016, 22:03

4 Medical Device Stocks on a Bull Run this Earnings Season

The expected positive third-quarter performance by the broader Medical sector is something investors definitely need to muse on.

26 октября 2016, 16:30

The Zacks Analyst Blog Highlights: AT&T, General Mills, Pfizer and Time Warner

The Zacks Analyst Blog Highlights: AT&T, General Mills, Pfizer and Time Warner

21 октября 2016, 16:30

The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals

The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals

20 октября 2016, 17:29

7 Drug Stocks to Consider as Biosimilars Pick Up Pace

Given the current scenario of increased political, media and public pressure on drug pricing, it makes sense to zero in on companies that are in the biosimilars business.

18 октября 2016, 16:41

Pfizer to Launch Remicade Biosimilar in U.S. in November

Pfizer Inc. (PFE) announced that its Inflectra injection, a biosimilar version of Johnson & Johnson's (JNJ) blockbuster drug Remicade, will be available in the U.S. in late November.

Выбор редакции
10 октября 2016, 20:41

Pfizer Divests Hospira Infusion Systems To ICU, Retaining An Interest In The Acquier

Pfizer Inc. (NYSE: PFE) recently announced that it has entered into definitive agreement with ICU Medical (NASDAQ: ICUI) to sell its infusion systems business, which it had received via the acquisition of Hospira last year. The deal is expected to close in first quarter of 2017. The small medical device [...]